Article Text

Download PDFPDF
Vinorelbine neurotoxicity: clinical and neurophysiological findings in 23 patients.
  1. A Pace,
  2. L Bove,
  3. C Nisticò,
  4. M Ranuzzi,
  5. P Innocenti,
  6. A Pietrangeli,
  7. E Terzoli,
  8. B Jandolo
  1. Neurology Service, Regina Elena National Cancer Institute, Rome, Italy.


    Vinorelbine (5'-noranhydrovinblastine) is a new semisynthetic antineoplastic vinca alkaloid which interfers with axonal transport, inducing spiralisation of axonal microtubules and resulting in peripheral neurotoxicity. A prospective detailed neurological and electrophysiological evaluation was performed in 23 patients treated with 25 mg vinorelbine a week. All patients developed a sensory-motor distal symmetric axonal neuropathy. The neurotoxicity increased with cumulative vinorelbine doses and peripheral neuropathy was mild or moderate in most patients. After discontinuation of vinorelbine treatment, neuropathic signs and symptoms were partially reversible.

    Statistics from

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.